Optimizing Lonafarnib Treatment for the Management of Chronic Delta Hepatitis: The Lowr HDV - 1 Study

Hepatology - United States
doi 10.1002/hep.29658
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Prenylation Inhibitor, Lonafarnib: A New Therapeutic Strategy Against Hepatitis Delta

The Lancet Infectious Diseases
Infectious Diseases
2015English

High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients With Chronic Hepatitis Delta

PLoS ONE
Multidisciplinary
2014English

Future Prospectives for the Management of Chronic Hepatitis B

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice

Liver International
Hepatology
2011English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Gender Influence on Treatment of Chronic Hepatitis C Genotype 1

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2010English

Historical Treatment of Chronic Hepatitis B and Chronic Hepatitis C.

Gut
Gastroenterology
1993English

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta

Hepatitis Monthly
HepatologyInfectious Diseases
2014English

Prospects for the Treatment of Patients With Chronic Viral Hepatitis With Cirrhosis

Vestnik of Saint Petersburg University. Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy